Joshua B. Muntner
CIK: 0001651911
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CRDF
Cardiff Oncology, Inc.
Officer
Discretionary Trading P&L
Holdings
About Muntner Joshua B
Muntner Joshua B (SEC CIK 0001651911) files insider reports with the SEC as Chief Financial Officer of Cardiff Oncology, Inc. (CRDF).
Signal8 holds 3 ownership filings by Muntner Joshua B (1 Form 3, 2 Form 4), filed on Apr 16, 2026. Those filings report 2 transactions, the latest on Apr 6, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Muntner Joshua B's filings is in SAN DIEGO, CA.
Recent filings by Muntner Joshua B
- Apr 6, 2026: Grants or awards of CRDF derivative securities (2 lines, Form 4, code A).
Other insiders filing for Cardiff Oncology, Inc. (CRDF)
- Alland Leila, Chief Medical Officer
- PACE GARY W, Director
- Mohindru Mani, Chief Executive Officer
- Armitage James O, Director
- White Lale, Director
- TANNENBAUM RENEE P, Director